Clinical Trials Directory

Trials / Completed

CompletedNCT02087735

Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts

Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Laval University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this cross over pilot study is to investigate the urinary catabolites of Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCranberry extractThe aim of this pilot study is to evaluate the urinary catabolites of PACs as a biomarker of consumption of cranberry extracts within 9 hours of intercourse. Once a week, for 3 weeks, the women will receive a sequence of 3 different cranberry extracts (72 mg, 36 mg and 2mg (placebo)). The participant will have to collect its urine for a period of 9 hours in 3 different containers (one different container for 3 hours).

Timeline

Start date
2014-01-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2014-03-14
Last updated
2016-10-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02087735. Inclusion in this directory is not an endorsement.

Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts (NCT02087735) · Clinical Trials Directory